CAR T‐cell expansion after idecabtagene vicleucel is a predictor of outcomes in multiple myeloma

HemaSphere · Published 2026-06-01 · DOI 10.1002/hem3.70391

Free full text

Authors (15)

Benoît Ferment, Amani Ouedrani, Alexis Talbot, Naouel Mouri, Pauline Zarnitzky, Romain Stammler, Tristan Vaugeois, Antoine Diep, Stephanie Harel, Bruno Royer, Floriane Theves, Nathalie Forgeard, Vincent Allain, Sophie Caillat‐Zucman, Bertrand Arnulf

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ferment, B., Ouedrani, A., Talbot, A., et al. (2026). CAR T‐cell expansion after idecabtagene vicleucel is a predictor of outcomes in multiple myeloma. HemaSphere. https://doi.org/10.1002/hem3.70391

Related articles